Analysts See More Than 60% Upside For These 4 Biotech Stocks
“Now that the global vaccination drive is in full flight, biotech companies are working on their research and development projects to advance new therapies to…
“Now that the global vaccination drive is in full flight, biotech companies are working on their research and development projects to advance new therapies to…
Tech companies involved in the software, cloud computing, mobile app and telecom sectors are among the new tech stocks to watch highlighted in today’s article,…
A slew of biotech companies studying blood disease treatments presented data this past weekend at the annual American Society of Hematology (ASH) meeting – and,…
From traditional “Big Pharma” stocks that have adopted (or are adopting) a greater focus on biotech to large “pure-play” biotech companies to “emerging” biotech stocks…
Amid a third-quarter earnings season that has been a mixed bag of beats and misses for drug/biotech companies, today’s article highlights five drug/biotech stocks that…
In March, two small biotechs partnered to develop a vaccine for COVID-19 using a mechanism called RNA interference (RNAi) – and early data for the…
Product candidates for the treatment of excessive underarm sweating on one hand, and dry eye disease on the other, could help the two stocks highlighted…
Noting that it launched against “perhaps the most consequential backdrop imaginable for the overall Biotech industry,” today’s article examines the recent performance of the Nasdaq…
Today’s article highlights “a trio of biotech companies scheduled to make initial public offerings this week in what appears to be a favorable climate for…
No matter what happens to the economy, people aren’t going to stop taking their prescription medications. As a result, the author of today’s article suggests…